- Funding to support ongoing clinical programs in seizure and psychiatric disorders and precision neuromedicine discovery platform- Raymond Kelleher, M.D., Ph.D., of lead investor Cormorant Asset Management, and James Healy, M.D., Ph.D., of Sofinnova Investments, join Board of DirectorsBOSTON & SAN DIEGO (BUSINESS.
San Diego- and Boston-based Rapport Therapeutics has raised $150M in a Series B funding round, the company said this morning. According to the company, the funding was led by Cormorant Asset Management,
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of warrants Net proceeds. -Today at 08:59 am- MarketScreener